Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 1, 2024Annals of Saudi MedicineOpen Access

Improved long-term survival rate in the responders to bortezomib, cyclophosphamide, dexamethasone induction therapy in a transplant-eligible cohort of predominantly middle-age multiple myeloma patients

View Full Paper
Ask AI
Bookmark
Share

Authors

AAAhmed Kotb AbdrabouFSFahad Al SharifRFRiad El Fakih

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Abdrabou et al. (2024) studied this question.

synapsesocial.com/papers/68e76b06b6db6435876e0b82https://doi.org/10.5144/0256-4947.2024.93
View Full Paper
Ask AI
Bookmark
Share